Will JHX report adjusted EBITDA below $275M in any quarter through Q2 FY2027?
Current Prediction
Why This Question Matters
Quarterly EBITDA is the most sensitive stress indicator. Current FY26 guidance implies ~$308-316M quarterly average. A quarter below $275M would imply annualized EBITDA below $1.1B, compressing interest coverage below 3.8x and pushing leverage above 3.5x — the escalation threshold for FUNDING_FRAGILITY. This tests the tail risk scenario from the Stress Scanner: if housing deteriorates further, does EBITDA compress enough to stress the capital structure?
Prediction Distribution
Individual Predictions(9 runs)
FY26 EBITDA guidance midpoint is ~$1,248M, implying ~$312M quarterly average. Q3 FY26 was $330M. The $275M threshold is roughly 12% below the average — a significant deterioration. The question spans Q4 FY26 through Q2 FY27 (3 quarters). For any quarter to drop below $275M would require either a severe seasonal dip or a material housing deterioration beyond current conditions. FY27 should benefit from cost synergies, plant closure savings, and potentially organic recovery. The floor appears well above $275M absent a severe macro shock.
The EBITDA floor analysis: Siding & Trim quarterly EBITDA was ~$269M in Q3. DR&A was ~$49M. ANZ and Europe add another ~$15-20M. Total quarterly EBITDA of ~$330M has significant buffer above $275M. For EBITDA to drop below $275M, organic volumes would need to accelerate declines materially OR margins would need to compress through input cost inflation. DR&A margins are volatile (30.7% in Q2 to 25.1% in Q3), which creates some risk in weaker quarters. But the combined floor with synergy support seems safely above $275M.
Even in the Q1 FY26 trough (the worst quarter with -15% organic volumes), quarterly EBITDA likely was not below $275M given the full-year guidance midpoint. With FY27 expected to show improvement (organic recovery, synergies, plant closures), the EBITDA floor should be HIGHER than FY26's weakest quarter. Sub-$275M would require a recession-level housing shock. I assign low probability to this tail risk scenario.
Building products have seasonal variation — Q1 FY (April-June) tends to be strong, but Q3 FY (October-December) can be weaker. The question covers Q4 FY26, Q1 FY27, and Q2 FY27. Seasonal patterns suggest Q4 FY26 (January-March) could be weaker. If housing starts decline further or weather disrupts spring building season, one quarter could approach $275M. DR&A margin volatility (30.7% to 25.1% in one quarter) shows earnings can swing. I'm slightly more concerned than low-teens probability suggests.
The stress test probability: if housing starts fell another 10% and volumes declined 5-8% beyond current levels, EBITDA would compress by approximately $50-75M quarterly — bringing it from $310-330M to $235-280M. This would breach $275M. But this scenario requires a meaningful worsening from already-weak conditions, which the Stress Scanner assessed as possible but not base case. I weight the tail risk at ~17%.
I assign slightly higher probability because the question only requires ONE quarter below $275M, not sustained performance. Seasonal weakness, an unexpected input cost spike, or a weather-related construction disruption could temporarily push one quarter below the threshold even without a macro shock. The 3-quarter window increases the chances. Additionally, FY26 guidance was cut significantly in Q1, demonstrating that management's forecasts can be wrong. A similar surprise in FY27 isn't impossible.
Current quarterly EBITDA of $330M provides significant buffer above $275M. FY27 should see improvement from synergies and organic recovery. Sub-$275M requires a severe deterioration that doesn't appear in the base case. Low probability tail risk.
3-quarter window with seasonal variation creates some possibility. But the buffer is substantial and the trajectory is improving. Housing would need to meaningfully worsen for EBITDA to breach $275M. Probability below 20%.
Tail risk scenario. Would require housing starts down 15%+ sustained or a significant one-time cost event. Cost synergies and plant closures are raising the EBITDA floor. Low but not negligible probability.
Resolution Criteria
Resolves YES if James Hardie reports adjusted EBITDA below $275M in any single quarter from Q4 FY2026 through Q2 FY2027 (January 2026 through December 2026), per quarterly earnings releases. Resolves NO if adjusted EBITDA remains at or above $275M in all quarters during this period.
Resolution Source
James Hardie quarterly earnings releases for Q4 FY2026 through Q2 FY2027
Source Trigger
Quarterly EBITDA falls below $275M (implying <$1.1B annual run rate)
Full multi-lens equity analysis